These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 6824782

  • 1. [Biochemical differences in the tumor cells of 5-fluorouracil-sensitive and -resistant strains of Ehrlich ascitic carcinoma].
    Shlemkevich MP.
    Biull Eksp Biol Med; 1983 Feb; 95(2):72-4. PubMed ID: 6824782
    [Abstract] [Full Text] [Related]

  • 2. [Effect of ascorbic acid on incorporation of 5-fluorouracil-6-3H into acid-soluble fraction and into RNA of sensitive and resistant to 5-fluorouracil cells of Ehrlich ascites carcinoma].
    Shlemkevich MP.
    Biull Eksp Biol Med; 1982 Feb; 93(2):56-7. PubMed ID: 7066528
    [No Abstract] [Full Text] [Related]

  • 3. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.
    Myers CE, Young RC, Chabner BA.
    Cancer Res; 1976 May; 36(5):1653-8. PubMed ID: 1268826
    [Abstract] [Full Text] [Related]

  • 4. Effect of N1-(2'-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on nucleic acid and protein biosyntheses in Ehrlich ascites cells.
    Fujimoto S, Akao T, Itoh B, Koshizuka I, Koyano K.
    Cancer Res; 1976 Jan; 36(1):33-6. PubMed ID: 1248008
    [Abstract] [Full Text] [Related]

  • 5. Intratumoral injection of thymidine: enhancement of the antitumor activity and incorporation of 5-fluorouracil into tumor RNA in a murine tumor system.
    Matsuoka H, Masuda H, Maehara Y, Sugimachi K, Inokuchi K.
    Cancer Treat Rep; 1986 Jul; 70(7):851-7. PubMed ID: 3719577
    [Abstract] [Full Text] [Related]

  • 6. [Characterization of a fluorouracil-resistant human gastric carcinoma cell line and its morphological behavior].
    Yue XF, Han JX, Dai ZQ, Liu MZ, Yang WY, Xu JY, Zhou JJ, Chen LJ, Zhang SY.
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14 Suppl():S1-4. PubMed ID: 8010063
    [Abstract] [Full Text] [Related]

  • 7. [Olivomycin-C14 distribution in the body of mice with Ehrlich's carcinoma resistant to the preparation].
    Vatin AE.
    Farmakol Toksikol; 1975 Nov; 38(2):224-6. PubMed ID: 1227896
    [Abstract] [Full Text] [Related]

  • 8. [Experimental studies on the uptake of anticancer drugs in cancer cells in hyperthermochemotherapy--effects of in vitro and in vivo heating on the uptake of 5-fluorouracil in Ehrlich cells].
    Yamane T.
    Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):254-65. PubMed ID: 3713678
    [Abstract] [Full Text] [Related]

  • 9. Stimulatory effects of inosine and deoxyinosine on the incorporation of uracil-2-14-C, 5-fluorouracil-2-14-C, and 5-bromouracil-2-14-C into nucleic acids by Ehrlich ascites tumor cells in vitro.
    Gotto AM, Belkhode ML, Touster O.
    Cancer Res; 1969 Apr; 29(4):807-11. PubMed ID: 5775710
    [No Abstract] [Full Text] [Related]

  • 10. [adenylate cyclase system in Ehrlich ascites tumor cells sensitive and resistant to 5-fluorouracil].
    Shlemkevich MP, Iurkiv VA, Melikhov VI.
    Ukr Biokhim Zh (1978); 1982 Apr; 54(1):76-9. PubMed ID: 7058556
    [Abstract] [Full Text] [Related]

  • 11. Selectivity of action of 5-FU: biochemical basis.
    Rustum YM, Danhauser L, Wang G.
    Bull Cancer; 1979 Apr; 66(1):43-7. PubMed ID: 154352
    [Abstract] [Full Text] [Related]

  • 12. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T, Suzuki N, Yamaguchi M, Ohshimo H, Fukushima M.
    Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
    [Abstract] [Full Text] [Related]

  • 13. [On uptake of 5-FU, 6-MP and methotrexate by ehrlich ascites tumor cells in vitro].
    Oriuchi T.
    Sapporo Igaku Zasshi; 1970 Jun; 37(6):255-67. PubMed ID: 5534721
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of DNA and RNA synthesis by daunorubicin in sensitive and resistant Ehrlich ascites tumor cells in vitro.
    Dano K, Frederiksen S, Hellung-Larsen P.
    Cancer Res; 1972 Jun; 32(6):1307-14. PubMed ID: 5063994
    [No Abstract] [Full Text] [Related]

  • 15. [Pharmacokinetics of fluoropyrimidines].
    Fujita H.
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2307-15. PubMed ID: 6437341
    [Abstract] [Full Text] [Related]

  • 16. [Mechanism of various degrees of tumor sensitivity to olivomycin].
    Reztsova VV.
    Antibiotiki; 1981 May; 26(5):391-3. PubMed ID: 7259149
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Estimation of pathways of 5-fluorouracil anabolism in human cancer cells in vitro and in vivo].
    Fukushima M, Nomura H, Murakami Y, Shirasaka T, Aiba K.
    Gan To Kagaku Ryoho; 1996 May; 23(6):721-31. PubMed ID: 8645024
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.